Cargando…
Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression
The ABCG2 membrane protein is a key xeno- and endobiotic transporter, modulating the absorption and metabolism of pharmacological agents and causing multidrug resistance in cancer. ABCG2 is also involved in uric acid elimination and its impaired function is causative in gout. Analysis of ABCG2 expre...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945641/ https://www.ncbi.nlm.nih.gov/pubmed/29749379 http://dx.doi.org/10.1038/s41598-018-25695-z |
_version_ | 1783322031345893376 |
---|---|
author | Zámbó, Boglárka Bartos, Zsuzsa Mózner, Orsolya Szabó, Edit Várady, György Poór, Gyula Pálinkás, Márton Andrikovics, Hajnalka Hegedűs, Tamás Homolya, László Sarkadi, Balázs |
author_facet | Zámbó, Boglárka Bartos, Zsuzsa Mózner, Orsolya Szabó, Edit Várady, György Poór, Gyula Pálinkás, Márton Andrikovics, Hajnalka Hegedűs, Tamás Homolya, László Sarkadi, Balázs |
author_sort | Zámbó, Boglárka |
collection | PubMed |
description | The ABCG2 membrane protein is a key xeno- and endobiotic transporter, modulating the absorption and metabolism of pharmacological agents and causing multidrug resistance in cancer. ABCG2 is also involved in uric acid elimination and its impaired function is causative in gout. Analysis of ABCG2 expression in the erythrocyte membranes of healthy volunteers and gout patients showed an enrichment of lower expression levels in the patients. By genetic screening based on protein expression, we found a relatively frequent, novel ABCG2 mutation (ABCG2-M71V), which, according to cellular expression studies, causes reduced protein expression, although with preserved transporter capability. Molecular dynamics simulations indicated a stumbled dynamics of the mutant protein, while ABCG2-M71V expression in vitro could be corrected by therapeutically relevant small molecules. These results suggest that personalized medicine should consider this newly discovered ABCG2 mutation, and genetic analysis linked to protein expression provides a new tool to uncover clinically important mutations in membrane proteins. |
format | Online Article Text |
id | pubmed-5945641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-59456412018-05-14 Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression Zámbó, Boglárka Bartos, Zsuzsa Mózner, Orsolya Szabó, Edit Várady, György Poór, Gyula Pálinkás, Márton Andrikovics, Hajnalka Hegedűs, Tamás Homolya, László Sarkadi, Balázs Sci Rep Article The ABCG2 membrane protein is a key xeno- and endobiotic transporter, modulating the absorption and metabolism of pharmacological agents and causing multidrug resistance in cancer. ABCG2 is also involved in uric acid elimination and its impaired function is causative in gout. Analysis of ABCG2 expression in the erythrocyte membranes of healthy volunteers and gout patients showed an enrichment of lower expression levels in the patients. By genetic screening based on protein expression, we found a relatively frequent, novel ABCG2 mutation (ABCG2-M71V), which, according to cellular expression studies, causes reduced protein expression, although with preserved transporter capability. Molecular dynamics simulations indicated a stumbled dynamics of the mutant protein, while ABCG2-M71V expression in vitro could be corrected by therapeutically relevant small molecules. These results suggest that personalized medicine should consider this newly discovered ABCG2 mutation, and genetic analysis linked to protein expression provides a new tool to uncover clinically important mutations in membrane proteins. Nature Publishing Group UK 2018-05-10 /pmc/articles/PMC5945641/ /pubmed/29749379 http://dx.doi.org/10.1038/s41598-018-25695-z Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Zámbó, Boglárka Bartos, Zsuzsa Mózner, Orsolya Szabó, Edit Várady, György Poór, Gyula Pálinkás, Márton Andrikovics, Hajnalka Hegedűs, Tamás Homolya, László Sarkadi, Balázs Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression |
title | Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression |
title_full | Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression |
title_fullStr | Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression |
title_full_unstemmed | Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression |
title_short | Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression |
title_sort | clinically relevant mutations in the abcg2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945641/ https://www.ncbi.nlm.nih.gov/pubmed/29749379 http://dx.doi.org/10.1038/s41598-018-25695-z |
work_keys_str_mv | AT zamboboglarka clinicallyrelevantmutationsintheabcg2transporteruncoveredbygeneticanalysislinkedtoerythrocytemembraneproteinexpression AT bartoszsuzsa clinicallyrelevantmutationsintheabcg2transporteruncoveredbygeneticanalysislinkedtoerythrocytemembraneproteinexpression AT moznerorsolya clinicallyrelevantmutationsintheabcg2transporteruncoveredbygeneticanalysislinkedtoerythrocytemembraneproteinexpression AT szaboedit clinicallyrelevantmutationsintheabcg2transporteruncoveredbygeneticanalysislinkedtoerythrocytemembraneproteinexpression AT varadygyorgy clinicallyrelevantmutationsintheabcg2transporteruncoveredbygeneticanalysislinkedtoerythrocytemembraneproteinexpression AT poorgyula clinicallyrelevantmutationsintheabcg2transporteruncoveredbygeneticanalysislinkedtoerythrocytemembraneproteinexpression AT palinkasmarton clinicallyrelevantmutationsintheabcg2transporteruncoveredbygeneticanalysislinkedtoerythrocytemembraneproteinexpression AT andrikovicshajnalka clinicallyrelevantmutationsintheabcg2transporteruncoveredbygeneticanalysislinkedtoerythrocytemembraneproteinexpression AT hegedustamas clinicallyrelevantmutationsintheabcg2transporteruncoveredbygeneticanalysislinkedtoerythrocytemembraneproteinexpression AT homolyalaszlo clinicallyrelevantmutationsintheabcg2transporteruncoveredbygeneticanalysislinkedtoerythrocytemembraneproteinexpression AT sarkadibalazs clinicallyrelevantmutationsintheabcg2transporteruncoveredbygeneticanalysislinkedtoerythrocytemembraneproteinexpression |